Effects of Vasopressin in Septic Shock

AACN Advanced Critical Care

Volumn 19, Issue 3, 2008, Pages 281-287

  Ruggiero, Margaret S ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Septic shock; V receptors; Vasopressin

Indexed keywords

ANGIOTENSIN II; NITRIC OXIDE; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

AGED; BLOOD PRESSURE; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG MONITORING; FEMALE; HEMODYNAMICS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTENSIVE CARE; METABOLISM; METHODOLOGY; NURSING ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SEPTIC SHOCK;

AGED; ANGIOTENSIN II; BLOOD PRESSURE; CRITICAL CARE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HEMODYNAMICS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NITRIC OXIDE; NURSING ASSESSMENT; PATIENT SATISFACTION; PITUITARY-ADRENAL SYSTEM; PRACTICE GUIDELINES AS TOPIC; RECEPTORS, VASOPRESSIN; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 55249123473     PISSN: 15597768     EISSN: 15597768     Source Type: Journal    
DOI: 10.1097/01.AACN.0000330379.34142.5b     Document Type: Article

References (25)

1. Wenzel R. Treating sepsis. N Engl J Med. 2002;347: 966-967.
2. Rughavin M, Marik P. Management of sepsis during the early golden hours. J Emerg Med. 2006;31:185-199.
3. Vincent J, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G. Reducing mortality in sepsis: new directions. Crit Care. 2002;6(suppl 3):S1-S18.
4. Dellinger RP, Carlet JM, Masur H, et al, for Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-873.
5. Lee C. Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock. Crit Care Nurse. 2006;26:17-23.
6. Bridges E, Dukes S. Cardiovascular aspects of septic shock; pathology, monitoring and treatment. Crit Care Nurse. 2005;25:14-42.
7. Vincent JL. Cardiovascular alterations in septic shock. J Antimicrob Chemother. 1998;41(suppl A):9-15.
8. Barrett L, Singer M, Clapp L. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35:33-40.
9. Brierre S, Kumari R, Deboisblanc B. The endocrine system during sepsis. Am J Med Sci. 2004;328:238-247.
10. Court O, Kumar A, Parrillo J, Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care. 2002;6:500-508.
11. Treshman T, Peters J. The vasopressin system. Physiology and clinical strategies. Anesthesiology. 2006;105:599-612.
12. Robertson G. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:2130-2133.
13. Johnson K, Renn C. The hypothalamic-pituitary-adrenal axis in critical illness. AACN Clin Issues. 2006;17:39-49.
14. Holmes C, Patel B, Russell J. Physiology of vasopressin relevant to management of septic shock. Chest. 2001; 120:989-1002.
15. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle W. Hemodynamic and metabolic effects of low-dose vasopressin infusion in vasodilatory shock. Crit Care Med. 2001;29:487-493.
16. Holmes C, Walley K, Chittock D, Lehman T, Russell J. The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med. 2001;27(8):1416-1421.
17. Sutherland A, Cordon A, Russell J. Are vasopressin levels increased or decreased in septic shock? Crit Care Med. 2006;34:542-543.
18. Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to bedside. Shock. 2003;20:197-207.
19. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877-887.
20. Russell JA. Vasopressin in septic shock. Crit Care Med. 2007;35:S609-S615.
21. Gessner P. The effects of vasopressin on the renal system in vasodilatory shock. Dimens Crit Care Nurs. 2006;25:1-8.
22. Edwards RM, Trizna W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonists. Am Physiol Soc. 1989;256:F274-F278.
23. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology. 2002;96:576-582.
24. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guideline for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
25. Wenzel R. Treating sepsis. N Engl J Med. 2002;347: 966-967.